Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yang-Xun Pan"'
Autor:
Chao-Xu Yang, Yang-Xun Pan, Feng Ye, Xiao-Dong Zhu, Jun Xue, Xi Li, Zhen-Gang Yuan, Lan Zhang, Li Xu, Yong-Jun Chen, Nan-Ya Wang, Hui-Chuan Sun, Xiu-Feng Liu, China Liver Cancer Study Group Young Investigators (CLEAP)
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundFor decades, stratification criteria for first-line clinical studies have been highly uniform. However, there is no principle or consensus for restratification after systemic treatment progression based on immune checkpoint inhibitors (ICIs
Externí odkaz:
https://doaj.org/article/3356a8d222e74518a0137217ece0f0dc
Autor:
Zhong‐Guo Zhou, Jin‐Bin Chen, Rong‐Xin Zhang, Ling Ye, Jun‐Cheng Wang, Yang‐Xun Pan, Xiao‐Hui Wang, Wen‐Xuan Li, Yao‐Jun Zhang, Li Xu, Min‐Shan Chen
Publikováno v:
Cancer Communications, Vol 40, Iss 8, Pp 355-369 (2020)
Abstract Background Hepatocellular carcinoma (HCC) is a major health problem and a primary cause of cancer‐related death worldwide. Although great advances have achieved recently by large‐scale high‐throughput analysis, the precise molecular me
Externí odkaz:
https://doaj.org/article/268a4b6db9e54bafa0ac29ae9919eefb
Autor:
Yang-Xun Pan, Jian-Cong Chen, Ai-Ping Fang, Xiao-Hui Wang, Jin-Bin Chen, Jun-Cheng Wang, Wei He, Yi-Zhen Fu, Li Xu, Min-Shan Chen, Yao-Jun Zhang, Qi-Jiong Li, Zhong-Guo Zhou
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-11 (2019)
Abstract Background Patients with hepatocellular carcinoma (HCC) undergoing surgical resection still have a high 5-year recurrence rate (~ 60%). With the development of laparoscopic hepatectomy (LH), few studies have compared the efficacy between LH
Externí odkaz:
https://doaj.org/article/304738053b46447aa26ca4cd09e3e25e
Autor:
Yang-Xun Pan, Yi-Zhen Fu, Dan-Dan Hu, Qian Long, Jun-Cheng Wang, Mian Xi, Shi-Liang Liu, Li Xu, Meng-Zhong Liu, Min-Shan Chen, Yao-Jun Zhang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Both stereotactic body radiotherapy (SBRT) and radiofrequency ablation (RFA) are effective local treatments for hepatocellular carcinoma (HCC), but whether RFA is superior to SBRT is still controversial. Therefore, we performed a meta-ana
Externí odkaz:
https://doaj.org/article/cb017e25c5ee487da2f30e3f701e2e1a